Please enable JavaScript to view advertisements.
×
App Icon
The Standard e-Paper
Home To Bold Columnists
★★★★ - on Play Store
Download App

Vaginal ring may help reduce HIV infections

A vaginal ring containing an antiviral drug is being tested in Africa and, if successful, could provide women with an easy-to-use alternative to vaginal microbicides to help reduce their risk of HIV infection.

The ring, which slowly releases the antiretroviral drug dapivirine over a period of time — removing the need for application each time a woman has sexual intercourse — has entered phase three efficacy trials in South Africa.

Premium Article

Get Full Access for Ksh299/Week.

Fact-first reporting that puts you at the heart of the newsroom. Subscribe for full access.
Continue Reading  →
What you get
  • Unlimited access to all premium content
  • Ad-free browsing experience
  • Mobile-optimised reading
  • Weekly newsletters & digests
Pay via
M - PESA
VISA
Airtel Money
Secure Payments Kenya's most trusted newsroom since 1902
Support Independent Journalism

Stand With Bold Journalism.
Stand With The Standard.

Journalism can't be free because the truth demands investment. At The Standard, we invest time, courage and skills to bring you accurate, factual and impactful stories. Subscribe today and stand with us in the pursuit of credible journalism.

Pay via
M - PESA
VISA
Airtel Money
Secure Payment Kenya's most trusted newsroom since 1902

Follow The Standard on Google News